[
  {
    "ts": null,
    "headline": "Trump's drug price order is part request, part threat: Analyst",
    "summary": "President Trump signed an executive order on Monday calling for pharmaceutical companies to cut their drug prices for US consumers. Bernstein Senior Analyst, US Biopharmaceuticals Courtney Breen comments on whether the Trump administration ultimately has the power to force drug companies to do this. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.",
    "url": "https://finnhub.io/api/news?id=d8f897935ba7a4a50063a61fa2f24998fe9bf1ec2d00f6721ed8763caed00d7f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747092000,
      "headline": "Trump's drug price order is part request, part threat: Analyst",
      "id": 134408474,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "President Trump signed an executive order on Monday calling for pharmaceutical companies to cut their drug prices for US consumers. Bernstein Senior Analyst, US Biopharmaceuticals Courtney Breen comments on whether the Trump administration ultimately has the power to force drug companies to do this. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.",
      "url": "https://finnhub.io/api/news?id=d8f897935ba7a4a50063a61fa2f24998fe9bf1ec2d00f6721ed8763caed00d7f"
    }
  },
  {
    "ts": null,
    "headline": "These Stocks Moved the Most Today: Amazon, Nvidia, Tesla, Alibaba, Eli Lilly, Pfizer, NRG Energy, Newmont, and More",
    "summary": "Amazon.com, Nvidia, Tesla, and the rest of the Magnificent Seven stocks jump as the U.S. and China reach an agreement to temporarily slash most tariffs on each other’s goods.",
    "url": "https://finnhub.io/api/news?id=5e959369a511b99d18477e21bc3fe6d2482e60c20f3e7747156cdb489787a33e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747081020,
      "headline": "These Stocks Moved the Most Today: Amazon, Nvidia, Tesla, Alibaba, Eli Lilly, Pfizer, NRG Energy, Newmont, and More",
      "id": 134408477,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Amazon.com, Nvidia, Tesla, and the rest of the Magnificent Seven stocks jump as the U.S. and China reach an agreement to temporarily slash most tariffs on each other’s goods.",
      "url": "https://finnhub.io/api/news?id=5e959369a511b99d18477e21bc3fe6d2482e60c20f3e7747156cdb489787a33e"
    }
  },
  {
    "ts": null,
    "headline": "How Trump could go about executing order to slash drug prices",
    "summary": "President Trump signed an executive order on Monday asking drugmakers to cut prices on their prescription drugs. Yahoo Finance consumer affairs reporter Jordan Weissmann reviews Trump's latest push to slash drug costs and how the administration may seek to go about it. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.",
    "url": "https://finnhub.io/api/news?id=a52f46ea96cc7f2bee0eca9dc418f58521acc508001fd2d07d07191ce2b8a2f9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747079446,
      "headline": "How Trump could go about executing order to slash drug prices",
      "id": 134408480,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "President Trump signed an executive order on Monday asking drugmakers to cut prices on their prescription drugs. Yahoo Finance consumer affairs reporter Jordan Weissmann reviews Trump's latest push to slash drug costs and how the administration may seek to go about it. To watch more expert insights and analysis on the latest market action, check out more Market Domination here.",
      "url": "https://finnhub.io/api/news?id=a52f46ea96cc7f2bee0eca9dc418f58521acc508001fd2d07d07191ce2b8a2f9"
    }
  },
  {
    "ts": null,
    "headline": "Trump Executive Order Could Reshape How Americans Pay for Drugs. Why It Isn’t Bad for Pharma Stocks.",
    "summary": "The Trump administration’s Monday executive order could restructure how Americans buy prescription drugs, pushing them away from insurers and pharmacy-benefit managers and toward cash-pay options.  A White House official said on a press call early Monday that a new executive order from President Donald Trump will push drugmakers to sell prescription drugs at low prices directly to patients.  President Trump signed the executive order shortly before 11 a.m. after a press conference in which he and top officials railed against the drug industry and painted the order as a blow against drugmakers.",
    "url": "https://finnhub.io/api/news?id=c85eaeebc2895b7b1416d31189f2e5c8040e300bbac9d05b92f5d449c2c98a56",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747076280,
      "headline": "Trump Executive Order Could Reshape How Americans Pay for Drugs. Why It Isn’t Bad for Pharma Stocks.",
      "id": 134408482,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The Trump administration’s Monday executive order could restructure how Americans buy prescription drugs, pushing them away from insurers and pharmacy-benefit managers and toward cash-pay options.  A White House official said on a press call early Monday that a new executive order from President Donald Trump will push drugmakers to sell prescription drugs at low prices directly to patients.  President Trump signed the executive order shortly before 11 a.m. after a press conference in which he and top officials railed against the drug industry and painted the order as a blow against drugmakers.",
      "url": "https://finnhub.io/api/news?id=c85eaeebc2895b7b1416d31189f2e5c8040e300bbac9d05b92f5d449c2c98a56"
    }
  },
  {
    "ts": null,
    "headline": "50 Fortune World's Most Admired Companies (FWMAC): 24 \"Safer\", 1 Ideal Buy",
    "summary": "These are my top dividend stock picks from Fortune Worldâs Most Admired Companies, May 2025 edition. Read the full report here on Seeking Alpha.",
    "url": "https://finnhub.io/api/news?id=ce6b1e455860c526dd2cb46bd7eb05e757c51e3c22b9d8bfeba114fe20621d90",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747074311,
      "headline": "50 Fortune World's Most Admired Companies (FWMAC): 24 \"Safer\", 1 Ideal Buy",
      "id": 134392206,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/678921557/image_678921557.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "These are my top dividend stock picks from Fortune Worldâs Most Admired Companies, May 2025 edition. Read the full report here on Seeking Alpha.",
      "url": "https://finnhub.io/api/news?id=ce6b1e455860c526dd2cb46bd7eb05e757c51e3c22b9d8bfeba114fe20621d90"
    }
  },
  {
    "ts": null,
    "headline": "Strategically Building A $500,000 Dividend Portfolio: Boosting SCHD's Income With May's High-Yield Picks",
    "summary": "Boost your portfolio with smart ETF picks! Explore high-yield dividends, diversified sector investments, and projected income growth in this comprehensive...",
    "url": "https://finnhub.io/api/news?id=3c2683e1f441d8591180acc200ba5acd85fc1c9068f45c420c1fb859ba641f7c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747072800,
      "headline": "Strategically Building A $500,000 Dividend Portfolio: Boosting SCHD's Income With May's High-Yield Picks",
      "id": 134392085,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1036558944/image_1036558944.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Boost your portfolio with smart ETF picks! Explore high-yield dividends, diversified sector investments, and projected income growth in this comprehensive...",
      "url": "https://finnhub.io/api/news?id=3c2683e1f441d8591180acc200ba5acd85fc1c9068f45c420c1fb859ba641f7c"
    }
  },
  {
    "ts": null,
    "headline": "Drug wars: Wall Street says big questions remain about impact of Trump's new pricing order",
    "summary": "Trump signed a new executive order Monday that would attempt to force drugmakers to lower pricing in the US compared to other developed nations.",
    "url": "https://finnhub.io/api/news?id=38b8b54a72fc5416372f7fd968c63e89179bca2e547813060953f9d149dde7b7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747067695,
      "headline": "Drug wars: Wall Street says big questions remain about impact of Trump's new pricing order",
      "id": 134408773,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Trump signed a new executive order Monday that would attempt to force drugmakers to lower pricing in the US compared to other developed nations.",
      "url": "https://finnhub.io/api/news?id=38b8b54a72fc5416372f7fd968c63e89179bca2e547813060953f9d149dde7b7"
    }
  },
  {
    "ts": null,
    "headline": "Trump expected to sign order to slash US drug prices",
    "summary": "President Trump is expected to sign an executive order intended to cut US prescription drug prices in order to match drug prices overseas. Yahoo Finance senior health reporter Anjalee Khemlani outlines the many steps and government agencies involved in investigating and carrying out this act. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.",
    "url": "https://finnhub.io/api/news?id=2fac8407bab8089ee6638e31408578326a93679e005cdef8d76c714e3eae16d7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747061072,
      "headline": "Trump expected to sign order to slash US drug prices",
      "id": 134381623,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "President Trump is expected to sign an executive order intended to cut US prescription drug prices in order to match drug prices overseas. Yahoo Finance senior health reporter Anjalee Khemlani outlines the many steps and government agencies involved in investigating and carrying out this act. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.",
      "url": "https://finnhub.io/api/news?id=2fac8407bab8089ee6638e31408578326a93679e005cdef8d76c714e3eae16d7"
    }
  },
  {
    "ts": null,
    "headline": "What has Trump said about cutting drug prices?",
    "summary": "U.S. President Donald Trump signed abroad executive order on Monday directing drugmakers to lowerthe prices of their prescription drugs to align with what othercountries pay. White...",
    "url": "https://finnhub.io/api/news?id=932ceb14531302a38ee9c0a2381add93951a7085617afb4d5310647d82ce2676",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747057991,
      "headline": "What has Trump said about cutting drug prices?",
      "id": 134389616,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "U.S. President Donald Trump signed abroad executive order on Monday directing drugmakers to lowerthe prices of their prescription drugs to align with what othercountries pay. White...",
      "url": "https://finnhub.io/api/news?id=932ceb14531302a38ee9c0a2381add93951a7085617afb4d5310647d82ce2676"
    }
  },
  {
    "ts": null,
    "headline": "Zacks.com featured highlights PCB, G-III Apparel, Gibraltar, Pfizer and Pampa Energia",
    "summary": "PCB, G-III Apparel, Gibraltar, Pfizer and Pampa Energia have been highlighted in this Screen of The Week article.",
    "url": "https://finnhub.io/api/news?id=dbbe923ba5e889bb28f036d899c0bf67701d21aff0de8290f87df1000250f32d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747056300,
      "headline": "Zacks.com featured highlights PCB, G-III Apparel, Gibraltar, Pfizer and Pampa Energia",
      "id": 134409137,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "PCB, G-III Apparel, Gibraltar, Pfizer and Pampa Energia have been highlighted in this Screen of The Week article.",
      "url": "https://finnhub.io/api/news?id=dbbe923ba5e889bb28f036d899c0bf67701d21aff0de8290f87df1000250f32d"
    }
  },
  {
    "ts": null,
    "headline": "US-China trade truce, April CPI, drug prices: 3 Things",
    "summary": "US stock futures (ES=F, NQ=F, YM=F) are surging Monday morning after US and China officials agreed to significant cuts to each country's respective tariff rates in a 90-day cool-off period. April's Consumer Price Index (CPI) is due out tomorrow, reporting month-over-month trends in US inflation rates. President Trump vows to cut prescription drug prices by as much as 80%. In turn, pharmaceutical stocks are seeing across the board pullbacks in pre-market trading. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.",
    "url": "https://finnhub.io/api/news?id=a938c055665a43b53f0a2cfa14795093ec3154f152ae163fa36fccfba6e48a3b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747055379,
      "headline": "US-China trade truce, April CPI, drug prices: 3 Things",
      "id": 134379227,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "US stock futures (ES=F, NQ=F, YM=F) are surging Monday morning after US and China officials agreed to significant cuts to each country's respective tariff rates in a 90-day cool-off period. April's Consumer Price Index (CPI) is due out tomorrow, reporting month-over-month trends in US inflation rates. President Trump vows to cut prescription drug prices by as much as 80%. In turn, pharmaceutical stocks are seeing across the board pullbacks in pre-market trading. To watch more expert insights and analysis on the latest market action, check out more Morning Brief here.",
      "url": "https://finnhub.io/api/news?id=a938c055665a43b53f0a2cfa14795093ec3154f152ae163fa36fccfba6e48a3b"
    }
  },
  {
    "ts": null,
    "headline": "These Stocks Are Moving the Most Today: Amazon, Nvidia, Tesla, Alibaba, Eli Lilly, Pfizer, RH, Newmont, and More",
    "summary": "Amazon.com, Nvidia, Tesla, and the rest of the Magnificent Seven stocks jump as the U.S. and China reach an agreement to temporarily slash most tariffs on each other’s goods, while Eli Lilly and Pfizer fall after President Donald Trump plans to sign an executive order that would reduce the cost of drugs in the U.S.",
    "url": "https://finnhub.io/api/news?id=66342666979fcde83bc5dd4acbe8c772e03dd3f8e71e70d5edb4be570b421ba7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747055040,
      "headline": "These Stocks Are Moving the Most Today: Amazon, Nvidia, Tesla, Alibaba, Eli Lilly, Pfizer, RH, Newmont, and More",
      "id": 134379091,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Amazon.com, Nvidia, Tesla, and the rest of the Magnificent Seven stocks jump as the U.S. and China reach an agreement to temporarily slash most tariffs on each other’s goods, while Eli Lilly and Pfizer fall after President Donald Trump plans to sign an executive order that would reduce the cost of drugs in the U.S.",
      "url": "https://finnhub.io/api/news?id=66342666979fcde83bc5dd4acbe8c772e03dd3f8e71e70d5edb4be570b421ba7"
    }
  },
  {
    "ts": null,
    "headline": "Zacks Market Edge Highlights: WHR, PFE, CVX, CC and DOW",
    "summary": "WHR, PFE, CVX, CC and DOW have been highlighted in this Market Edge article.",
    "url": "https://finnhub.io/api/news?id=cef5ed2d3f6f4a5f7f9d3a15e16b835ed2b51ee51d7b3dc9e39b28c38dff2852",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747054200,
      "headline": "Zacks Market Edge Highlights: WHR, PFE, CVX, CC and DOW",
      "id": 134381522,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "WHR, PFE, CVX, CC and DOW have been highlighted in this Market Edge article.",
      "url": "https://finnhub.io/api/news?id=cef5ed2d3f6f4a5f7f9d3a15e16b835ed2b51ee51d7b3dc9e39b28c38dff2852"
    }
  },
  {
    "ts": null,
    "headline": "Trump Declares War On Pharma Drug Pricing, But The Stocks Aren't Tanking - Yet",
    "summary": "Trump aims to cut US drug prices by 30-80% via Executive Order. Check out how pharma companies could be affected and how this may play out in the future.",
    "url": "https://finnhub.io/api/news?id=f3bdfb278b3d923fb7ecd9a0eb0a6ca51ad748153503c12329641a35d2d60c57",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747053003,
      "headline": "Trump Declares War On Pharma Drug Pricing, But The Stocks Aren't Tanking - Yet",
      "id": 134386076,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1756275584/image_1756275584.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "Trump aims to cut US drug prices by 30-80% via Executive Order. Check out how pharma companies could be affected and how this may play out in the future.",
      "url": "https://finnhub.io/api/news?id=f3bdfb278b3d923fb7ecd9a0eb0a6ca51ad748153503c12329641a35d2d60c57"
    }
  },
  {
    "ts": null,
    "headline": "Trump Executive Order Reshapes How Americans Pay for Drugs. Why It Isn’t Bad for Pharma Stocks.",
    "summary": "Trump Executive Order Reshapes How Americans Pay for Drugs. Why It Isn’t Bad for Pharma Stocks.",
    "url": "https://finnhub.io/api/news?id=af5b4ecb8b18eb30bc64e99d843a62e1036afca940ad279f70fdb98e2995aa97",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747048140,
      "headline": "Trump Executive Order Reshapes How Americans Pay for Drugs. Why It Isn’t Bad for Pharma Stocks.",
      "id": 134382834,
      "image": "",
      "related": "PFE",
      "source": "MarketWatch",
      "summary": "Trump Executive Order Reshapes How Americans Pay for Drugs. Why It Isn’t Bad for Pharma Stocks.",
      "url": "https://finnhub.io/api/news?id=af5b4ecb8b18eb30bc64e99d843a62e1036afca940ad279f70fdb98e2995aa97"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer, Eli Lilly, Merck and Other Pharma Stocks Fall as Trump Targets Lower Drug Prices",
    "summary": "Shares of pharmaceutical companies dropped early Monday after President Donald Trump said he would lower the cost of medicines for Americans by 59%.  Shares of major U.S. drugmakers  Eli Lilly Pfizer Merck AbbVie  and  Amgen  fell between 2.4% and 4.3% in premarket trading Monday.  The U.S. is the largest market for many global pharmaceutical companies, partly because of higher prices.",
    "url": "https://finnhub.io/api/news?id=47a39c86dd44bb5d036c37fde583aa7df5427ad596f3a9fdfb9d2166d7ec8dbf",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747050540,
      "headline": "Pfizer, Eli Lilly, Merck and Other Pharma Stocks Fall as Trump Targets Lower Drug Prices",
      "id": 134379231,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Shares of pharmaceutical companies dropped early Monday after President Donald Trump said he would lower the cost of medicines for Americans by 59%.  Shares of major U.S. drugmakers  Eli Lilly Pfizer Merck AbbVie  and  Amgen  fell between 2.4% and 4.3% in premarket trading Monday.  The U.S. is the largest market for many global pharmaceutical companies, partly because of higher prices.",
      "url": "https://finnhub.io/api/news?id=47a39c86dd44bb5d036c37fde583aa7df5427ad596f3a9fdfb9d2166d7ec8dbf"
    }
  },
  {
    "ts": null,
    "headline": "Trump’s Vow to Cut US Drug Prices Drags Pharma Stocks Lower",
    "summary": "(Bloomberg) -- President Donald Trump said he plans to order a cut in US prescription drug costs to bring them in line with other countries, spurring a drop in pharmaceutical shares worldwide.Most Read from BloombergA New Central Park Amenity, Tailored to Its East Harlem NeighborsAs Trump Reshapes Housing Policy, Renters Face Rollback of RightsWhat’s Behind the Rise in Serious Injuries on New York City’s Streets?Is Trump’s Plan to Reopen the Notorious Alcatraz Prison Realistic?NYC Warns of 17% D",
    "url": "https://finnhub.io/api/news?id=0ed68ac2f804ddcc0a1868fcbb1408e4d02677fcb05f84f561f6989bfb263898",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747049896,
      "headline": "Trump’s Vow to Cut US Drug Prices Drags Pharma Stocks Lower",
      "id": 134379232,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "(Bloomberg) -- President Donald Trump said he plans to order a cut in US prescription drug costs to bring them in line with other countries, spurring a drop in pharmaceutical shares worldwide.Most Read from BloombergA New Central Park Amenity, Tailored to Its East Harlem NeighborsAs Trump Reshapes Housing Policy, Renters Face Rollback of RightsWhat’s Behind the Rise in Serious Injuries on New York City’s Streets?Is Trump’s Plan to Reopen the Notorious Alcatraz Prison Realistic?NYC Warns of 17% D",
      "url": "https://finnhub.io/api/news?id=0ed68ac2f804ddcc0a1868fcbb1408e4d02677fcb05f84f561f6989bfb263898"
    }
  },
  {
    "ts": null,
    "headline": "Trump’s Plan to Cut Drug Prices Hits Pfizer, Other Pharma Stocks",
    "summary": "Drugmakers' shares fell globally after President Trump said he would sign an executive order to lower the cost of prescription drugs.  Shares of Japan's Daiichi Sankyo, which gets about a third of revenue from the U.S., dropped around 8%.  Other Japanese drug stocks also fell.",
    "url": "https://finnhub.io/api/news?id=c7b51c213def4142ff2c32e1b0901638ef8fd99996aee419d6955e61b558ed42",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747049600,
      "headline": "Trump’s Plan to Cut Drug Prices Hits Pfizer, Other Pharma Stocks",
      "id": 134381615,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Drugmakers' shares fell globally after President Trump said he would sign an executive order to lower the cost of prescription drugs.  Shares of Japan's Daiichi Sankyo, which gets about a third of revenue from the U.S., dropped around 8%.  Other Japanese drug stocks also fell.",
      "url": "https://finnhub.io/api/news?id=c7b51c213def4142ff2c32e1b0901638ef8fd99996aee419d6955e61b558ed42"
    }
  },
  {
    "ts": null,
    "headline": "Shareholders Will Be Pleased With The Quality of Pfizer's (NYSE:PFE) Earnings",
    "summary": "When companies post strong earnings, the stock generally performs well, just like Pfizer Inc.'s ( NYSE:PFE ) stock has...",
    "url": "https://finnhub.io/api/news?id=6db8f2d3ecc159ee70b1028fd03b25e539da936996430943d3da429132252a53",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747048311,
      "headline": "Shareholders Will Be Pleased With The Quality of Pfizer's (NYSE:PFE) Earnings",
      "id": 134379440,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "When companies post strong earnings, the stock generally performs well, just like Pfizer Inc.'s ( NYSE:PFE ) stock has...",
      "url": "https://finnhub.io/api/news?id=6db8f2d3ecc159ee70b1028fd03b25e539da936996430943d3da429132252a53"
    }
  },
  {
    "ts": null,
    "headline": "Pharma Shares Fall Pre-Bell Following Plan by Trump to Reduce US Prescription Drug Prices",
    "summary": "Pfizer (PFE), AstraZeneca (AZN), Johnson & Johnson (JNJ), and other drug company shares fell in Mond",
    "url": "https://finnhub.io/api/news?id=931cb133eabc132bc908b721e68a603b27763d222df4f19ce71abf9002024097",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747043715,
      "headline": "Pharma Shares Fall Pre-Bell Following Plan by Trump to Reduce US Prescription Drug Prices",
      "id": 134379270,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer (PFE), AstraZeneca (AZN), Johnson & Johnson (JNJ), and other drug company shares fell in Mond",
      "url": "https://finnhub.io/api/news?id=931cb133eabc132bc908b721e68a603b27763d222df4f19ce71abf9002024097"
    }
  },
  {
    "ts": null,
    "headline": "Wondering if Pfizer's 7.6% Dividend Yield Is Sustainable? Here's What You Need to Know.",
    "summary": "Pfizer can cover its dividends with free cash flow, but doesn't have a huge cushion.  The company faces some risks from pipeline setbacks, patent expirations, and U.S. government policies.  Its dividend appears to be sustainable despite the uncertainties.",
    "url": "https://finnhub.io/api/news?id=fa947b4bcae21975a36acad15a5aac6bd5e26ec13b868e4392c8983a8805b90c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747039860,
      "headline": "Wondering if Pfizer's 7.6% Dividend Yield Is Sustainable? Here's What You Need to Know.",
      "id": 134379442,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer can cover its dividends with free cash flow, but doesn't have a huge cushion.  The company faces some risks from pipeline setbacks, patent expirations, and U.S. government policies.  Its dividend appears to be sustainable despite the uncertainties.",
      "url": "https://finnhub.io/api/news?id=fa947b4bcae21975a36acad15a5aac6bd5e26ec13b868e4392c8983a8805b90c"
    }
  },
  {
    "ts": null,
    "headline": "Pharmaceutical Stocks Tumble on Trump Plan to Cut US Drug Prices",
    "summary": "(Bloomberg) -- Shares of pharmaceutical companies fell across the world after US President Donald Trump said he planned to order a cut in US prescription drug costs to bring them in line with other countries, prompting concern that profits will take a hit.Most Read from BloombergA New Central Park Amenity, Tailored to Its East Harlem NeighborsAs Trump Reshapes Housing Policy, Renters Face Rollback of RightsWhat’s Behind the Rise in Serious Injuries on New York City’s Streets?Is Trump’s Plan to R",
    "url": "https://finnhub.io/api/news?id=803a34c4b75b272c31602fdb892079821fd3c2013e3b55a564d6bf5776762dd1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747038493,
      "headline": "Pharmaceutical Stocks Tumble on Trump Plan to Cut US Drug Prices",
      "id": 134379236,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "(Bloomberg) -- Shares of pharmaceutical companies fell across the world after US President Donald Trump said he planned to order a cut in US prescription drug costs to bring them in line with other countries, prompting concern that profits will take a hit.Most Read from BloombergA New Central Park Amenity, Tailored to Its East Harlem NeighborsAs Trump Reshapes Housing Policy, Renters Face Rollback of RightsWhat’s Behind the Rise in Serious Injuries on New York City’s Streets?Is Trump’s Plan to R",
      "url": "https://finnhub.io/api/news?id=803a34c4b75b272c31602fdb892079821fd3c2013e3b55a564d6bf5776762dd1"
    }
  },
  {
    "ts": null,
    "headline": "Trump Renews Push for Most-Favored-Nation Drug Pricing. What It All Means.",
    "summary": "Trump Renews Push for Most-Favored-Nation Drug Pricing. What It All Means.",
    "url": "https://finnhub.io/api/news?id=2f17615fa3dc3229d7cead908effa15fa28091274631f5b10eb144d739354714",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747013400,
      "headline": "Trump Renews Push for Most-Favored-Nation Drug Pricing. What It All Means.",
      "id": 134382838,
      "image": "",
      "related": "PFE",
      "source": "MarketWatch",
      "summary": "Trump Renews Push for Most-Favored-Nation Drug Pricing. What It All Means.",
      "url": "https://finnhub.io/api/news?id=2f17615fa3dc3229d7cead908effa15fa28091274631f5b10eb144d739354714"
    }
  },
  {
    "ts": null,
    "headline": "High-Quality Dividend Growth Stocks Near 52-Week Lows: Alphabet Is Astounding",
    "summary": "A list of high-quality dividend-growth stocks trading near 52-week lows is evaluated. Read what makes GOOG stock is a compelling investment.",
    "url": "https://finnhub.io/api/news?id=271defdcaa1d7c4f740989245dac0be0fae96377b5585e7fe2fa2cba60148ce3",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747013223,
      "headline": "High-Quality Dividend Growth Stocks Near 52-Week Lows: Alphabet Is Astounding",
      "id": 134374993,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1400200369/image_1400200369.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "A list of high-quality dividend-growth stocks trading near 52-week lows is evaluated. Read what makes GOOG stock is a compelling investment.",
      "url": "https://finnhub.io/api/news?id=271defdcaa1d7c4f740989245dac0be0fae96377b5585e7fe2fa2cba60148ce3"
    }
  }
]